GLP
Scope
Date
~
-
Bio & Pharma
Kobiolabs gets Chinese patent for obesity treatment strain
South Korean microbiome-based new drug development company Kobiolabs Co. announced on Wednesday that it has a patent for its obesity treatment strai...
Jan 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharm to develop obesity drug customized for S.Korean
South Korea's Hanmi Pharmaceutical Co. plans to develop the GLP-1 class "Epeglenatide," which it received as a technology return from Sanofi S.A., i...
Jul 31, 2023 (Gmt+09:00)
-
Real estate
IGIS beats Blackstone, Brookfield in Asian real estate AUM
IGIS Asset Management Co., South Korea’s largest real estate asset manager, was ranked as the world’s second-largest asset management ...
Nov 24, 2021 (Gmt+09:00)
-
Artificial intelligence
NPS, KIC commit $600 mn to N.America logistics fund
The National Pension Service (NPS) and the Korea Investment Corporation (KIC) have committed $600 million in aggregate to GLP Capital Partners' Nort...
May 28, 2021 (Gmt+09:00)